2/12/2014 7:26:16 AM
In 2006, the research and development arm of British pharmaceutical giant GlaxoSmithKline (GSK) began undergoing a transformative process, creating smaller but more efficient units to drive the discovery and development of new medicines. Between 2009 and 2013, the company delivered 10 new medicines, five times the amount of new medicines that it delivered in twice the number of years between 1998 and 2006. In 2013, it delivered five new medicines, the highest number in the industry's history in any given year.
Help employers find you! Check out all the jobs and post your resume.
comments powered by